Usefulness of McRAPD for typing and importance of biofilm production in a case of nosocomial ventriculoperitoneal shunt infection caused by Candida lusitaniae

Folia Microbiologica

Volumn 56, Issue 5, 2011, Pages 407-414

  Hamal, Petr ^a   Hanzen, Juraj ^b   Horn, Frantisek ^c   Trtkova, Jitka ^a   Ruskova, Lenka ^a   Vecerova, Renata ^a   Ruzicka, Filip ^d   Vollekova, Anna ^b   Raclavsky, Vladislav ^a  

^a PALACKÝ UNIVERSITY   (Czech Republic)

^b HPL spol s ro   (Slovakia)

^c Physics and Informatics   (Slovakia)

^d MASARYK UNIVERSITY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT;

ARTICLE; ASTROCYTOMA; BIOFILM; BRAIN TUMOR; BRAIN VENTRICLE PERITONEUM SHUNT; CANDIDA; CANDIDIASIS; CASE REPORT; CEREBROSPINAL FLUID; CHILD; CROSS INFECTION; DNA DENATURATION; DRUG EFFECT; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN; HYDROCEPHALUS; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; PATHOLOGY; PULSED FIELD GEL ELECTROPHORESIS; RANDOM AMPLIFIED POLYMORPHIC DNA; TREATMENT FAILURE;

ANTIFUNGAL AGENTS; ASTROCYTOMA; BIOFILMS; BRAIN NEOPLASMS; CANDIDA; CANDIDIASIS; CHILD; CROSS INFECTION; ELECTROPHORESIS, GEL, PULSED-FIELD; HUMANS; HYDROCEPHALUS; MALE; MICROBIAL SENSITIVITY TESTS; MYCOLOGICAL TYPING TECHNIQUES; NUCLEIC ACID DENATURATION; RANDOM AMPLIFIED POLYMORPHIC DNA TECHNIQUE; TREATMENT FAILURE; VENTRICULOPERITONEAL SHUNT;

CLAVISPORA LUSITANIAE;

EID: 80053653788     PISSN: 00155632     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12223-011-0063-8     Document Type: Article

References (49)

1. Bachmann SP, VandeWalle K, Ramage G, Patterson TF, Wickes BL, Graybill JR, López-Ribot JL (2002) In vitro activity of caspofungin against Candida albicans biofilms. Antimicrob Agents Chemother 46: 3591-3596.
2. Bariola JR, Saccente M (2008) Candida lusitaniae septic arthritis: case report and review of the literature. Diagn Microbiol Infect Dis 61: 61-63.
3. Cauda R (2009) Candidaemia in patients with an inserted medical device. Drugs 69(Suppl 1): 33-38.
4. Choi JH, Jung HY, Kim HS, Cho HG (2000) PhyloDraw: a phylogenetic tree drawing system. Bioinformatics 16: 1056-1058.
5. Cinar S, Nedret Koc A, Taskapan H, Dogukan A, Tokgoz B, Utas C (2002) Case report. Candida lusitaniae peritonitis in a patient on continuous ambulatory peritoneal dialysis. Mycoses 45: 120-122.
6. Deschaght P, van Simaey L, Decat E, van Mechelen E, Brisse S, Vaneechoutte M (2011) Rapid genotyping of Achromobacter xylosoxidans, Acinetobacter baumannii, Klebsiella pneumoniae, Pseudomonas aeruginosa and Stenotrophomonas maltophilia isolates using melting curve analysis of RAPD-generated DNA fragments (McRAPD). Res Microbiol 162: 386-392.
7. Estrada B, Mancao MY, Polski JM, Figarola MS (2006) Candida lusitaniae and chronic granulomatous disease. Pediatr Infect Dis J 25: 758-759.
8. Favel A, Michel-Nguyen A, Peyron F, Martin C, Thomachot L, Datry A, Bouchara JP, Challier S, Noël T, Chastin C, Regli P (2003) Colony morphology switching of Candida lusitaniae and acquisition of multidrug resistance during treatment of a renal infection in a newborn: case report and review of the literature. Diagn Microbiol Infect Dis 47: 331-339.
9. Felsenstein J (1989) PHYLIP-phylogeny inference package (version 3. 2). Cladistics 5: 164-166.
10. Fowler SL, Rhoton B, Springer SC, Messer SA, Hollis RJ, Pfaller MA (1998) Evidence for person-to-person transmission of Candida lusitaniae in a neonatal intensive-care unit. Infect Control Hosp Epidemiol 19: 343-345.
11. Hamal P, Kappe R, Rimek D (2001) Rate of transmission and endogenous origin of Candida albicans and Candida glabrata on adult intensive care units studied by pulsed field gel electrophoresis. J Hosp Infect 49: 37-42.
12. Hawkins JL, Baddour LM (2003) Candida lusitaniae infections in the era of fluconazole availability. Clin Infect Dis 36: e14-e18.
13. Hazen KC (1995) New and emerging yeast pathogens. Clin Microbiol Rev 8: 462-478.
14. Holzschu DL, Presley HL, Miranda M, Phaff HJ (1979) Identification of Candida lusitaniae as an opportunistic yeast in humans. J Clin Microbiol 10: 202-205.
15. Huttova M, Kralinsky K, Horn J, Marinova I, Iligova K, Fric J, Spanik S, Filka J, Uher J, Kurak J, Krcmery V Jr (1998) Prospective study of nosocomial fungal meningitis in children-report of 10 cases. Scand J Infect Dis 30: 485-487.
16. Iwaguchi SI, Sato M, Magee BB, Magee PT, Makimura K, Suzuki T (2001) Extensive chromosome translocation in a clinical isolate showing the distinctive carbohydrate assimilation profile from a candidiasis patient. Yeast 18: 1035-1046.
17. King D, Rhine-Chalberg J, Pfaller MA, Moser SA, Merz WG (1995) Comparison of four DNA-based methods for strain delineation of Candida lusitaniae. J Clin Microbiol 33: 1467-1470.
18. Kjaeldgaard P, Schultz KS, Nielsen K, Stenderup J (1990) Fatal catheter septicemia with finding of Candida lusitaniae. Ugeskr Laeger 152: 611-612.
19. Kovacicova G, Hanzen J, Pisarcikova M, Sejnova D, Horn J, Babela R, Svetlansky I, Lovaszova M, Gogova M, Krcmery V (2001) Nosocomial fungemia due to amphotericin B-resistant Candida spp. in three pediatric patients after previous neurosurgery for brain tumors. J Infect Chemother 7: 45-48.
20. Krcmery V Jr, Mateicka F, Grausova S, Kunova A, Hanzen J (1999) Invasive infections due to Clavispora lusitaniae. FEMS Immunol Med Microbiol 23: 75-78.
21. Kuhn DM, Chandra J, Mukherjee PK, Ghannoum MA (2002a) Comparison of biofilms formed by Candida albicans and Candida parapsilosis on bioprosthetic surfaces. Infect Immun 70: 878-888.
22. Kuhn DM, George T, Chandra J, Mukherjee PK, Ghannoum MA (2002b) Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins. Antimicrob Agents Chemother 46: 1773-1780.
23. Lachance MA, Phaff HJ (1998) Genus Clavispora Rodrigues de Miranda. In: Kurtzman CP, Fell JW (eds) The yeasts, a taxonomic study, 4th edn. Elsevier Science, Amsterdam, pp 148-150.
24. Leggiadro RJ, Collins T (1988) Postneurosurgical Candida lusitaniae meningitis. Pediatr Infect Dis J 7: 368-369.
25. Li X, Yan Z, Xu J (2003) Quantitative variation of biofilms among strains in natural populations of Candida albicans. Microbiology 149: 353-362.
26. Liu D, Coloe S, Jones SL, Baird R, Pedersen J (1996) Genetic speciation of Candida isolates by arbitrarily primed polymerase chain reaction. FEMS Microbiol Lett 145: 23-26.
27. Mermel LA, Farr BM, Sherertz RJ, Raad II, O'Grady N, Harris JS, Craven DE, Infectious Diseases Society of America American College of Critical Care Medicine Society for Healthcare Epidemiology of America (2001) Guidelines for the management of intravascular catheter-related infections. Clin Infect Dis 32: 1249-1272.
28. Merz WG, Khazan U, Jabra-Rizk MA, Wu LC, Osterhout GJ, Lehmann PF (1992) Strain delineation and epidemiology of Candida (Clavispora) lusitaniae. J Clin Microbiol 30: 449-454.
29. Michel RG, Kinasewitz GT, Drevets DA, Levin JH, Warden DW (2009) Prosthetic valve endocarditis caused by Candida lusitaniae, an uncommon pathogen: a case report. J Med Case Reports 3: 7611.
30. Michel-Nguyen A, Favel A, Penaud A, Trousson F, Carlotti A (1996) Unusual case of Candida lusitaniae infection in a severely immunocompromised patient-multiple localizations of a single infective strain documented by restriction endonuclease analysis. J Mycol Med 6: 172-177.
31. Pfaller MA, Messer SA, Hollis RJ (1994) Strain delineation and antifungal susceptibilities of epidemiologically related and unrelated isolates of Candida lusitaniae. Diagn Microbiol Infect Dis 20: 127-133.
32. Plachy R, Hamal P, Raclavsky V (2005) McRAPD as a new approach to rapid and accurate identification of pathogenic yeasts. J Microbiol Methods 60: 107-113.
33. Ramage G, Vande Walle K, Wickes BL, López-Ribot JL (2001) Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms. Antimicrob Agents Chemother 45: 2475-2479.
34. Ramage G, Martinez JP, Lopez-Ribot JL (2006) Candida biofilms on implanted biomaterials: a clinically significant problem. FEMS Yeast Res 6: 979-986.
35. Ruskova L, Raclavsky V (2011) The potential of high resolution melting analysis (HRMA) to streamline, facilitate and enrich routine diagnostics in medical microbiology. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. doi: 10. 5507/bp. 2011. 045.
36. Ruzicka F, Hola V, Votava M, Tejkalova R (2007) Importance of biofilm in Candida parapsilosis and evaluation of its susceptibility to antifungal agents by colorimetric method. Folia Microbiol 52: 209-214.
37. Sanchez PJ, Cooper BH (1987) Candida lusitaniae: sepsis and meningitis in a neonate. Pediatr Infect Dis J 6: 758-759.
38. Sanchez V, Vazquez JA, Barth-Jones D, Dembry L, Sobel JD, Zervos MJ (1992) Epidemiology of nosocomial acquisition of Candida lusitaniae. J Clin Microbiol 30: 3005-3008.
39. Sanchez-Sousa A, Tarrago D, Velasco J, Alvarez ME, Baquero F (2001) Adherence to polystyrene of clinically relevant isolates of Candida species. Clin Microbiol Infect 7: 379-382.
40. Sarma PS, Durairaj P, Padhye AA (1993) Candida lusitaniae causing fatal meningitis. Postgrad Med J 69: 878-880.
41. Silverman NS, Morgan M, Nichols WS (2001) Candida lusitaniae as an unusual cause of recurrent vaginitis and its successful treatment with intravaginal boric acid. Infect Dis Obstet Gynecol 9: 245-247.
42. Soll DR (2000) The ins and outs of DNA fingerprinting the infectious fungi. Clin Microbiol Rev 13: 332-370.
43. Steffan P, Vazquez JA, Boikov D, Xu C, Sobel JD, Akins RA (1997) Identification of Candida species by randomly amplified polymorphic DNA fingerprinting of colony lysates. J Clin Microbiol 35: 2031-2039.
44. Trtkova J, Pavlicek P, Ruskova L, Hamal P, Koukalova D, Raclavsky V (2009) Performance of optimized McRAPD in identification of 9 yeast species frequently isolated from patient samples: potential for automation. BMC Microbiol 9: 234.
45. Tulsiani SM, Craig SB, Graham GC, Cobbold RC, Dohnt MF, Burns MA, Jansen CC, Leung LK, Field HE, Smythe LD (2010) High-resolution melt-curve analysis of random amplified polymorphic DNA (RAPD-HRM) for the characterisation of pathogenic leptospires: intra-serovar divergence, inter-serovar convergence, and evidence of attenuation in Leptospira reference collections. Ann Trop Med Parasitol 104: 427-437.
46. Tumbarello M, Posteraro B, Trecarichi EM, Fiori B, Rossi M, Porta R, de Gaetano DK, La Sorda M, Spanu T, Fadda G, Cauda R, Sanguinetti M (2007) Biofilm production by Candida species and inadequate antifungal therapy as predictors of mortality for patients with candidemia. J Clin Microbiol 45: 1843-1850.
47. Viudes A, Peman J, Canton E, Salavert M, Ubeda P, López-Ribot JL, Gobernado M (2002) Two cases of fungemia due to Candida lusitaniae and a literature review. Eur J Clin Microbiol Infect Dis 21: 294-299.
48. Yildirim M, Ozaydin I, Sahin I, Yasar M (2008) Acute calculous cholecystitis caused by Candida lusitaniae: an unusual causative organism in a patient without underlying malignancy. Jpn J Infect Dis 61: 138-139.
49. Yinnon AM, Woodin KA, Powell KR (1992) Candida lusitaniae infection in the newborn: case report and review of the literature. Pediatr Infect Dis J 11: 878-880.